Hepatic Venous Pressure Gradient Versus Endoscopic Ultrasound-Guided Portal Pressure Gradient - Comparative Analysis (HEPCA)
Recruiting
N/A
Interventional Study
Cirrhosis
Portal Hypertension
EUS
Non-Cirrhotic Portal Hypertension
HVPG
Hepatic Venous Pressure Gradient
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 75
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 40 (estimated)
- Sponsor
- Military University Hospital, Prague · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this interventional trial is to compare in measuring of portal hypertension by HVPG and EUS-PPG in subject indicated to HVPG measurement.
The primary question is whether EUS-PPG provides measurements really equivalent to HVPG in terms of gradient accuracy.
Participants undergoing HVPG will first undergo the procedure while conscious, performed by the first operator. Immediately there…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age 18-75 years at the time of enrollment; signed informed consent
* Clinical indication for HVPG measurement and/or transjugular liver biopsy for chronic advanced liver disease
Exclusion Criteria:
* Severe co-morbidities (e.g., advanced chronic heart failure, chronic renal …
Contacts